Psychometric Assessment of the Injection Pen Assessment Questionnaire (IPAQ): Measuring ease of use and preference with injection pens for human growth hormone

Health and Quality of Life Outcomes

Volumn 10, Issue , 2012, Pages

  Pleil, Andreas M ^a   Kimel, Miriam ^b   McCormack, Julie ^c   Rajicic, Natasa ^a   Hey Hadavi, Judith ^a  

^a PFIZER INC   (United States)

^b UNITED BIOSOURCE CORPORATION   (United States)

^c ICON PLC   (United Kingdom)

Author keywords

Ease of use; Growth hormone (GH); Injection device (pen); Parent child dyads; Patient reported outcome

Indexed keywords

HUMAN GROWTH HORMONE;

ADULT; ALGORITHM; ARTICLE; CHILD; CLINICAL EVALUATION; FEMALE; HUMAN; INJECTION PEN ASSESSMENT QUESTIONNAIRE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PSYCHOMETRY; QUALITATIVE RESEARCH; RATING SCALE; SCHOOL CHILD; SCORING SYSTEM;

FACTOR ANALYSIS, STATISTICAL; FEMALE; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INJECTIONS, JET; INJECTIONS, SUBCUTANEOUS; MALE; NEEDLES; PATIENT PREFERENCE; PSYCHOMETRICS; QUESTIONNAIRES; SYRINGES;

EID: 84867130213     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-10-126     Document Type: Article

References (24)

1. Mayo Clinic Human growth hormone (hGH): Does it slow aging process? Retrieved March 1, 2008 from http://www.mayoclinic.com/health/growth-hormone/HA00030., Mayo Clinic.
2. Human Growth Foundation Pediatric Growth Hormone Deficiency. Retrieved March 1, 2008, from Retrieved March 1, 2008 Retrieved March 1, 2008 from http://www.hgfound.org/pub_growth.html., Human Growth Foundation.
3. Dumas H, Panayiotopoulos P, Parker D, Pongpairochana V. Understanding and meeting the needs of those using growth hormone injection devices. BMC Endocr Disord 2006, 6(1):5. 10.1186/1472-6823-6-5, 1618831, 17034628.
4. Brunner HI, Klein-Gitelman MS, Miller MJ, Trombley M, Baldwin N, Kress A, Johnson AL, Barron AC, Griffin TA, Passo MH, Lovell DJ. Health of children with chronic arthritis: relationship of different measures and the quality of parent proxy reporting. Arthritis Rheum 2004, 51(5):763-773. 10.1002/art.20689, 15478144.
5. Levi RB, Drotar D. Health-related quality of life in childhood cancer: discrepancy in parent-child reports. Int J Cancer Suppl 1999, 12:58-64.
6. Waters E, Stewart-Brown S, Fitzpatrick R. Agreement between adolescent self-report and parent reports of health and well-being: results of an epidemiological study. Child Care Health Dev 2003, 29(6):501-509. 10.1046/j.1365-2214.2003.00370.x, 14616908.
7. Eiser C, Morse R. The measurement of quality of life in children: past and future perspectives. J Dev Behav Pediatr 2001, 22(4):248-256. 10.1097/00004703-200108000-00007, 11530898.
8. Upton P, Lawford J, Eiser C. Parent-child agreement across child health-related quality of life instruments: a review of the literature. Qual Life Res 2008, 17(6):895-913. 10.1007/s11136-008-9350-5, 18521721.
9. Varni JW, Seid M, Smith Knight T, Burwinkle T, Brown J, Szer IS. The PedsQL in pediatric rheumatology: reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory Generic Core Scales and Rheumatology Module. Arthritis Rheum 2002, 46(3):714-725. 10.1002/art.10095, 11920407.
10. Ungar WJ, Mirabelli C, Cousins M, Boydell KM. A qualitative analysis of a dyad approach to health-related quality of life measurement in children with asthma. Soc Sci Med 2006, 63(9):2354-2366. 10.1016/j.socscimed.2006.06.016, 16887248.
11. Food & Drug Administration 2009, Guidance for Industry - Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims, Silver Spring, MD: FDA, 3505647, 23213569.
12. Hey-Hadavi J, Pleil A, Deeb LC, Fuqua JS, Silverman LA, Reiner B, Newfield R, Rajicic N, Wajnrajch MP, Cara JF. Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-Month, single-arm, open-label clinical trial in patient-caregiver dyads. Clin Ther 2010, 32(12):2036-2047. 10.1016/j.clinthera.2010.11.007, 21118739.
13. Hu L, Bentler P. Cut off criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Structure Equation Modeling 1999, 6(1):1-55.
14. Hays R, Revicki D. Assessing reliability and validity, including responsiveness. Quality of Life Assessment in Clinical Trials 2005, New York: Oxford University Press, Fayers P, Hays R, 2.
15. Nunnally J, Bernstein I. Psychometric Theory 1994, New York: McGraw Hill, 3.
16. Cohen J. Statistical power analysis for the behavioral sciences 1988, Hillsdale, NJ: Lawrence Erlbaum Associates, 2.
17. Dahlgren J, Veimo D, Johansson L, Bech I. Patient acceptance of a novel electronic auto-injector device to administer recombinant human growth hormone: results from an open-label, user survey of everyday use. Curr Med Res Opin 2007, 23(7):1649-1655. 10.1185/030079907X210589, 17559757.
18. D'Eliseo P, Blaauw J, Milicevic Z, Wyatt J, Ignaut DA, Malone JK. Patient acceptability of a new 3.0 ml pre-filled insulin pen. Curr Med Res Opin 2000, 16(2):125-133.
19. Szeinbach SL, Barnes JH, Summers KH, Lenox SM. Development of an instrument to assess expectations of and preference for an insulin injection pen compared with the vial and syringe. Clin Ther 2004, 26(4):590-597. 10.1016/S0149-2918(04)90061-6, 15189756.
20. Venekamp WJ, Kerr L, Dowsett SA, Johnson PA, Wimberley D, McKenzie C, Malone J, Milicevic Z. Functionality and acceptability of a new electronic insulin injection pen with a memory feature. Curr Med Res Opin 2006, 22(2):315-325. 10.1185/030079906X80477, 16466603.
21. Bozzola M, Colle M, Halldin-Stenlid M, Larroque S, Zignani M, easypod survey study, g. Treatment adherence with the easypod growth hormone electronic auto-injector and patient acceptance: survey results from 824 children and their parents. BMC Endocr Disord 2011, 11:4. 10.1186/1472-6823-11-4, 3045978, 21294891, easypod survey study, g..
22. Etschmaier M, Kimel M, McCormack J, Hey-Hadavi J, Cara J. Development of the Injection Pen Assessment Questionnaire (IPAQ) to evaluate a new device to administer human growth hormone 2009, Orlando, FL: Paper presented at the ISPOR 14th Annual International Meeting.
23. Leidy NK, Revicki DA, Geneste B. Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health 1999, 2(2):113-127. 10.1046/j.1524-4733.1999.02210.x, 16674343.
24. Revicki DA, Osoba D, Fairclough D, Barofsky I, Berzon R, Leidy NK, Rothman M. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 2000, 9(8):887-900. 10.1023/A:1008996223999, 11284208.